Behic Selman Erdogdu, Mustafa Yontem, Fatma Emel Kocak, Hayrullah Yazar


Background: Decreased concentration of both oestrogen hormone and vitamin D in postmenopausal period may lead to oxidative stress, lipid peroxidation, dyslipidaemia, osteoporosis, and cardiovascular diseases. The objectives of this study were to determine and compare the serum levels of oxidative stress parameters; TOS, TAS, OSI, PON-1, ARYL in postmenopausal and fertile women of Kutahya city, Turkey.

Materials & Methods: This cross-sectional study was conducted at Department of Biochemistry, Faculty of Medicine, Kutahya University of Health Sciences, Kutahya, Turkey from July, 2020 to September, 2020. Kutahya is a city in western Turkey, with population of 237,804 as per 2011 estimates. Two samples were drawn from this population with consecutive technique. Study group included 40 menopausal women, while control group included 40 healthy fertile women. After overnight fasting, venous blood samples were collected, centrifuged, aliquoted into a polystyrene tube, and aliquots were stored at -80°C until measurement for total oxidant status (TOS), total antioxidant status (TAS), paraoxonase-1 (PON-1), and arylesterase (ARYL) measurements were made. Levels of TOS, TAS, OSI, PON-1, ARYL were five research variables on ratio scale. ‘Normal’ data were described by mean, range and SD and skewed data by median, Q1, Q3 and IQR with 95% confidence intervals. For normal data, independent-samples t-test and for skewed data Mann–Whitney U test was used for hypotheses testing.

Results: Serum total oxidant status (TOS) and oxidative stress index (OSI) levels were significantly higher (p-value .015 & .003 respectively), and serum paraoxonase-1 (PON-1) and arylesterase (ARYL) levels were significantly lower in postmenopausal than fertile women (p-value <.0001 & .0005 respectively), with no statistical difference for serum total antioxidant status (TAS) levels between the two groups (p-value .186).  

Conclusion: Postmenopausal period is associated with oxidative stress and decreased antioxidant defence. HDL-c-dependent PON-1 and ARYL activities are also reducing due to a decrease of HDL-c with menopause. Elevated levels of TOS and OSI, decreased levels of PON-1 and ARYL may lead to various life-threatening diseases such as cardiovascular disorders or cancer.


Antioxidants; Menopause; Postmenopause; Postmenopausal Period; Oxidative Stress; Arylesterase; Paraoxonase-1; Women.

Full Text:



Dalal PK, Agarwal M. Postmenopausal syndrome. Indian J Psychiatry 2015;57(Suppl 2):S222.

Siddle N, Sarrel P, Whitehead M. The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil Steril 1987;47(1):94-100.

Greendale GA, Lee NP, Arriola ER. The menopause. Lancet 1999;353(9152):571-80.

Sánchez-Rodríguez MA, Zacarías-Flores M, Arronte-Rosales A, Correa-Muñoz E, Mendoza-Núñez VM. Menopause as risk factor for oxidative stress. Menopause 2012;19(3):361-7.

Burger HG. The endocrinology of the menopause. Maturitas 1996;23(2):129-36.

Baltacıoğlu E, Akalın FA, Alver A, Balaban F, Ünsal M, Karabulut E. Total antioxidant capacity and superoxide dismutase activity levels in serum and gingival crevicular fluid in post-menopausal women with chronic periodontitis. J Clin Periodontol 2006;33(6):385-92.

Carr AC, McCall MR, Frei B. Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. Arterioscler Thromb Vasc Biol 2000;20(7):1716-23.

Behl C. Estrogen can protect neurons: modes of action. J Steroid Biochem Mol Biol 2002;83(1-5):195-7.

Amrita J, Mahajan M, Bhanwer AJS, Mohan G. Oxidative stress: an effective prognostic tool for an early detection of cardiovascular disease in menopausal women. Biochem Res Int 2016;2016.

Basu S, Michaëlsson K, Olofsson H, Johansson S, Melhus H. Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun 2001;288(1):275-9.

Vural P, Akgül C, Canbaz M. Effects of menopause and tibolone on antioxidants in postmenopausal women. Ann Clin Biochem 2005;42(3):220-3.

Ha BJ. Oxidative stress in ovariectomy menopause and role of chondroitin sulfate. Arch Pharm Res 2004;27(8):867-72.

Karakurt Ö, Çağırıcı G, Akdemir R. Paraoksonaz ve Ateroskleroz. Turkiye Klin Cardiovasc Sci 2012;24(2):128-33.

Litvinov D, Mahini H, Garelnabi M. Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases. N Am J Med Sci 2012;4(11):523.

Bacchetti T, Ferretti G, Sahebkar A. The role of paraoxonase in cancer. Semin Cancer Biol 2019 Jun;56:72-86.

Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN. The human serum paraoxonase/ arylesterase gene (PON1) is one member of a multigene family. Genomics 1996 May 1;33(3):498-507.

Topçuoglu A, Uzun H, Aydin S, Kahraman N, Vehid S, Zeybek G, et al. The effect of hormone replacement therapy on oxidized low density lipoprotein levels and paraoxonase activity in postmenopausal women. Tohoku J Exp Med 2005 Jan;205(1):79-86.

Sahin M, Bobusoglu O, Yetim A, Ates F. Paraoxonase-1 and arylesterase levels in patients with ulcerative colitis. Arab J Gastroenterol 2019;20(1):14-8.

Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38(12):1103-11.

Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37(2):112-9.

Eckerson HW, Wyte CM, La Du BN. The human serum paraoxonase/ arylesterase polymorphism. Am J Hum Genet 1983;35(6):1126.

Altindag O, Erel O, Soran N, Celik H, Selek S. Total oxidative/ anti-oxidative status and relation to bone mineral density in osteoporosis. Rheumatol Int 2008;28(4):317-21.

Klisic A, Kavaric N, Vujcic S, Spasojevic-Kalimanovska V, Kotur-Stevuljevic J, Ninic A. Total oxidant status and oxidative stress index as indicators of increased Reynolds Risk Score in postmenopausal women. Eur Rev Med Pharmacol Sci 2020;24(19):10126-33.

Zhao F, Guo L, Wang X, Zhang Y. Correlation of oxidative stress-related biomarkers with postmenopausal osteoporosis: a systematic review and meta-analysis. Arch Osteoporos 2021;16(1):4.

Dikker O, Şahin M, Atar S, Bekpınar S. Examination of oxidative stress markers in women with postmenopausal osteoporosis. Turk J Osteoporos 2018;24:15-20.

Zovari F, Parsian H, Bijani A, Moslemnezhad A, Shirzad A. Evaluation of salivary and serum total antioxidant capacity and lipid peroxidation in postmenopausal women. Int J Dent 2020 Nov 17;2020:8860467.

Bednarek-Tupikowska G, Tupikowski K, Bidzińska B, Bohdanowicz-Pawlak A, Antonowicz-Juchniewicz J, Kosowska B, et al. Serum lipid peroxides and total antioxidant status in postmenopausal women on hormone replacement therapy. Gynecol Endocrinol 2004;19(2):57-63.

Kolesnikova L, Semenova N, Madaeva I, Suturina L, Solodova E, Grebenkina L, et al. Antioxidant status in peri- and postmenopausal women. Maturitas [Internet] 2015;81(1):83-7.

Vassalle C, Sciarrino R, Bianchi S, Battaglia D, Mercuri A, Maffei S. Sex-related differences in association of oxidative stress status with coronary artery disease. Fertil Steril [Internet]. 2012;97(2):414-419.e2. Available at:

Auro K, Joensuu A, Fischer K, Kettunen J, Salo P, Mattsson H, vd. A metabolic view on menopause and ageing. Nat Commun [Internet] 2014;5(1):4708.

de Aloysio D, Gambacciani M, Meschia M, Pansini F, Modena AB, Bolis PF, et al. The effect of menopause on blood lipid and lipoprotein levels. Atherosclerosis 1999;147(1):147-53.

Poehlman ET, Toth MJ, Ades PA, Rosen CJ. Menopause-associated changes in plasma lipids, insulin-like growth factor I and blood pressure: a longitudinal study. Eur J Clin Invest 1997;27(4):322-6.

Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis [Internet] 1993;98(1):83-90.

Kilim SR, Chandala SR. A comparative study of lipid profile and oestradiol in pre-and post-menopausal women. J Clin Diagnostic Res 2013;7(8):1596.

Mešalić L, Tupković E, Kendić S, Balić D. Correlation between hormonal and lipid status in women in menopause. Bosn J Basic Med Sci 2008;8(2):188.

Igweh JC, Nwagha IU, Okaro JM. The effects of menopause on the serum lipid profile of normal females of South East Nigeria. Niger J Physiol Sci 2005;20(1):48-53.

Usoro CAO, Adikwuru CC, Usoro IN, Nsonwu AC. Lipid profile of postmenopausal women in Calabar, Nigeria. Pak J Nutr 2006;5(1):79-82.

Tunstall-Pedoe H. Myth and paradox of coronary risk and the menopause. Lancet 1998;351(9113):1425-7.

Sutherland WHF, Manning PJ, de Jong SA, Allum AR, Jones SD, Williams SM. Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women. Metab Exp 2001;50(3):319-24.

Mogarekar MR, Kulkarni SK. Small dense low density lipoprotein cholesterol, paraoxonase 1 and lipid profile in postmenopausal women: quality or quantity? Arch Med Res [Internet] 2015;46(7):534-8.

Kumru S, Aydin S, Aras A, Gursu MF, Gulcu F. Effects of surgical menopause and estrogen replacement therapy on serum paraoxonase activity and plasma malondialdehyde concentration. Gynecol Obstet Invest 2005;59(2):108-12.

Çavdaroğlu B, Köse N, Başkol G, Demir H. Evaluation of protein and lipid oxidative stress in the patients with postmenopausal osteoporosis. Dicle Med J 2014;41(1). 71-7.

Zago V, Sanguinetti S, Brites F, Berg G, Verona J, Basilio F, et al. Impaired high density lipoprotein antioxidant activity in healthy postmenopausal women. Atherosclerosis [Internet] 2004;177(1):203-10.

Kabaroglu C, Mutaf I il, Boydak B, Özmen D, Habif S, Erdener D, et al. Association between serum paraoxonase activity and oxidative stress in acute coronary syndromes. Acta Cardiol 2004;59(6):606-11.

Gaillard T, Parthasarathy S, Osei K. HDL dysfunctionality (paraoxonase) is worse in nondiabetic, postmenopausal African American than in white women. Diabetes Care 2011;34(2):e19-e19.

Butorac D, Ćelap I, Kačkov S, Robić V, Miletić T, Flegar Meštrić ZFM, et al. Paraoxonase 1 activity and phenotype distribution in premenopausal and postmenopausal women. Biochem Medica 2014;24(2):273-80.



  • There are currently no refbacks.

Copyright (c) 2021. Behic Selman Erdogdu, Mustafa Yontem, Fatma Emel Kocak, Hayrullah Yazar

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Gomal Medical College, Daraban Road, Dera Ismail Khan, Pakistan

ISSN: 1819-7973, e-ISSN: 1997-2067


Phone: +92-966-747373

Scimago Journal & Country Rank